School of Medicine
Showing 10,201-10,300 of 13,058 Results
-
Heather Selby, PhD
Basic Life Research Scientist, Stanford-Surgery Policy Improvement Research and Education Center
BioI am interested in developing medical imaging-based AI models to identify patients with locally advanced rectal cancer who achieve a clinical complete response to neoadjuvant chemoradiotherapy, with the goal of sparing them from surgery and its associated risks.
-
Zachary M. Sellers, MD, PhD
Adjunct Professor, Pediatrics - Gastroenterology
BioDr. Sellers is a pediatric physician-scientist and research and clinical development consultant. As a pediatric gastroenterologist and ion channel physiologist, Dr. Sellers' work in academia and pharma over the last 20 years has focused on improving the lives of individuals with complex and rare diseases through providing cutting-edge clinical care and advancing research and drug development. Dr. Sellers previously led a basic and translational research laboratory at Stanford, focused on epithelial ion transport and acid-base regulation using a variety of human and animal models. He is a firm believer in the exponential impact of team science and is adept working in multi-disciplinary and cross-functional teams. He seeks out strategic partnerships and opportunities that can leverage his expertise and leadership to advance innovative therapies for areas of high unmet need and to support the development of the next generation of physician-scientists. Dr. Sellers received his BS (Animal Physiology and Neuroscience) and BA (Japanese Studies) from the University of California. San Diego, his MD and PhD (Molecular and Integrative Physiology) from the University of Illinois at Urbana-Champaign, and was trained in Pediatrics and Pediatric Gastroenterology, Hepatology, and Nutrition at Stanford, where he was previously a faculty member and attending physician. He held multiple leadership positions at Stanford, including Associate Chief of Research in Gastroenterology, Director of the Stanford Children's Pancreas Program, Lead Gastroenterologist for the CF Program, Director of the CFTR Phenotyping and Theratyping Program, and Physician-Scientist Advisor for the Pediatrics Residency Program.
-
Deborah Sellmeyer
Clinical Professor, Medicine - Endocrinology, Gerontology, & Metabolism
BioDr. Sellmeyer is an internationally recognized expert in Metabolic Bone Disease. She is a renowned clinician who joined the Stanford faculty in 2018 as a Professor of Medicine. She has been recognized for her clinical excellence with induction into the Miller Coulson Academy of Clinical Excellence while she was at Johns Hopkins. In addition to her clinical expertise, Dr. Sellmeyer maintains a research program that centers on the effect of nutrition and environmental factors on skeletal metabolism which she has investigated through both smaller CRC-based trials and large multi-center trials. Studies she has conducted have investigated the role of dietary sodium chloride, source of dietary protein (animal, vegetable, dairy, soy), role of dietary potassium and alkaline potassium salts, targeted thoracic exercises on kyphosis, whether structured exercise can prevent bone loss in premenopausal women treated for breast cancer, and studies validating nutritional assessment questionnaires. Her expertise as a clinical researcher has enabled development of a multi-disciplinary translational research team including basic scientists in the orthopedic department, junior faculty members with K grant funding, and basic scientists in the endocrine division to develop translational projects studying the effects of osteoporosis medications on basic elements of skeletal biology utilizing bone biopsies from treated individuals as well as clinical trials of novel therapies for rare bone disorders. Dr. Sellmeyer also is a esteemed educator, having received multiple teaching awards.
-
Subhro K. Sen, MD
Clinical Associate Professor, Surgery - Plastic & Reconstructive Surgery
BioSubhro K. Sen, MD, Clinical Associate Professor in the Division of Plastic and Reconstructive Surgery, graduated from Northwestern University with a degree in biomedical engineering. He went on to receive his medical degree from the Northwestern University Feinberg School of Medicine. After medical school, he completed a yearlong peripheral nerve research fellowship under Dr. Susan Mackinnon at the Washington University School of Medicine in St. Louis. He completed his postgraduate training in general surgery at Indiana University, followed by plastic and reconstructive surgery at Johns Hopkins University. He finished his training with a hand and upper extremity surgery fellowship at Stanford University.
Dr. Sen’s general clinical interests are in reconstructive surgery, microvascular surgery, and hand and upper extremity surgery. His practice includes: post-traumatic extremity reconstruction; post-oncologic reconstruction of the head and neck, trunk and extremities; perforator flap surgery; and melanoma surgery. He is medical director of the Advanced Wound Care Center at Stanford Health Care. As a hand surgeon in the Robert A. Chase Hand and Upper Limb Center, he has interests in hand trauma, degenerative conditions, peripheral nerve injuries, and complex upper extremity flap reconstruction.
In addition to his clinical practice, Dr. Sen is involved in research, publication, and teaching. His peer-reviewed research includes studies on extremity reconstruction, peripheral nerve regeneration, and he has authored a number of book chapters on a variety of plastic and hand surgery topics. He has a strong interest in medical device innovation and is currently a faculty fellow in the Stanford Byers Center for Biodesign.
Dr. Sen is certified by the American Board of Plastic Surgery and the American Board of Surgery. He is a member of the American Society of Plastic Surgeons, the American Society for Surgery of the Hand, and the American Society of Reconstructive Microsurgery. -
Sourya Sengupta
Postdoctoral Scholar, Urology
Current Research and Scholarly InterestsMultimodal medical AI, vision language models, model interpretability, computational imaging science
-
Yasir Sepah
Assistant Professor (Research) of Ophthalmology
Current Research and Scholarly InterestsYasir's primary focus is on early identification of ocular diseases and objective assessment of response to therapy via biomarker (imaging and molecular) discovery and endpoints development for clinical trials. His lab is also developing and implementing protocols and methods to make decentralized clinical trials in ophthalmology viable.
Yasir is also engaged in developing low-tech, low cost and less intelligent solutions in order to improve patient's access to care. -
Jennifer Andrene Sequoia
Instructor, Pediatrics - Neonatology
BioJennifer Sequoia, MD, PhD is an Instructor in Neonatology at Stanford University. She completed her Neonatology Fellowship and Pediatrics Residency (Research Track) at Stanford. Prior to coming to Stanford she received her undergraduate and master's degrees from University of California, San Diego and her MD and PhD degrees from The University of Chicago. As faculty at Stanford, she is developing a research program to understand how endogenous cannabinoids impact preeclampsia and other perinatal diseases. She is broadly interested in how lipids mediate inflammatory programs and is working to develop new molecular tools to study lipids in their native environments.
-
Yaffa Serur Schwarzman
Postdoctoral Scholar, Psychiatry
BioChildren and Adolescent Psychiatrist
-
Shebani Sethi MD, ABOM
Clinical Associate Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsImproving metabolic and mental health through dietary metabolic therapies, pharmacological optimization, and other lifestyle interventions in those with severe mental illness, such as bipolar disorder, schizophrenia, major depression is a major focus of her research. Clinical and academic interests include management of psychiatric disorders with co-morbid obesity, insulin resistance, metabolic dysfunction and/or eating disorders, particularly binge eating disorder and bulimia nervosa.
-
Kawin Setsompop
Professor of Radiology (Radiological Sciences Laboratory) and, by courtesy, of Electrical Engineering
BioKawin Setsompop is a Professor of Radiology and, by courtesy, of Electrical Engineering. His research focuses on the development of novel MRI acquisition methods, with the goal of creating imaging technologies that can be used to help better understand brain structure and function for applications in Healthcare and Health sciences. He received his Master’s degree in Engineering Science from Oxford University and his PhD in Electrical Engineering and Computer Science from MIT. Prior to joining Stanford, he was a postdoctoral fellow and subsequently a faculty at the A.A. Martinos center for biomedical imaging, MGH, as well as part of the Harvard and MIT faculty. His group has pioneered several widely-used MRI acquisition technologies, a number of which have been successfully translated into FDA-approved clinical products on Siemens, GE, Phillips, United Imaging and Bruker MRI scanners worldwide. These technologies are being used daily to study the brain in both clinical and neuroscientific fields.
-
Shaun P. Setty
Clinical Assistant Professor, Cardiothoracic Surgery
BioDr. Setty is Surgical Director of the Cardiac Intensive Care Unit, Director of Global Cardiac Care, and a member of the pediatric cardiac surgery team. Dr. Setty completed his general surgery residency at Oregon Health Sciences University and spent an infolded year during his training at Green Lane Hospital in New Zealand as a research and pediatric/ adult cardiac surgery fellow. He then spent 3 years at the University of Minnesota/ Lillehei Heart Institute, the birthplace of cardiac surgery, completing his cardiothoracic surgery training. He performed his congenital heart surgery fellowship at the Royal Children’s Hospital in Melbourne, Australia. Dr. Setty is triple-board-certified in surgery, thoracic surgery, & congenital heart surgery. He has past experience in all aspects of pediatric and adult congenital cardiac surgery including neonatal and transplant surgery. He is a member of the medical school honor society, Alpha Omega Alpha. Dr. Setty also has numerous peer-reviewed publications, book chapters, and research presentations to his credit.
His current research focus includes: cardiac surgery outcomes with genetic syndromes, social determinants of health and its effect on cardiac surgery outcomes, big data in international cardiac surgery humanitarian centers, and the epigenetic delineation of congenital heart disease. -
Zachary Aaron Sexton
Postdoctoral Scholar, Cardiology
BioFocused on understanding cardiovascular physiology, disease, and tissue engineering through stem cell biology and hemodynamics. Specializes in 3D extrusion bioprinting and computational fluid dynamics (though an open-source software platform SimVascular) to improve tissue engineering strategies for the successful development of cardiac tissues for disease modeling and therapeutic solutions.
-
Sharon Sha, MD, MS
Clinical Professor, Adult Neurology
BioDr. Sha is a Clinical Professor of Neurology and Neurological Sciences at Stanford University where she serves as Chief for the Memory Disorders Division and the Stanford Memory Disorders Center, Associate Vice Chair of Clinical Research, Director of the Huntington’s Disease Center of Excellence and Ataxia Clinic, Co-Director of the Lewy Body Disease Association Research Center of Excellence, and Clinical Core Co-Leader of the Stanford Alzheimer's Disease Research Center. Her clinical time is devoted to caring for patients with Alzheimer’s disease and other neurodegenerative disorders and her research is devoted to finding treatments for these cognitive disorders. She also served on the California Governor’s Alzheimer’s Prevention and Preparedness Task Force Chaired by Maria Shriver in 2020. She has been featured in international media and documentaries such as the BBC "How to Stay Young" and the Docuseries "Limitless with Chris Hemsworth".
-
Ross Shachter
Associate Professor of Management Science and Engineering
Current Research and Scholarly InterestsProf. Shachter's research has focused on the representation, manipulation, and analysis of uncertainty and probabilistic reasoning in decision systems. As part of this work, he developed the DAVID influence diagram processing system for the Macintosh. He has developed models scheduling patients for cancer follow-up, and analyzing vaccination strategies for HIV and Helobacter pylori.
-
Audrey Shafer
Professor of Anesthesiology, Perioperative and Pain Medicine, Emeritum
Current Research and Scholarly Interestsliterature and medicine, humanistic aspects of medicine and anesthesia care, language and medicine, communication, medical humanities, creative writing, arts and healthcare
-
Robert W. Shafer
Professor (Research) of Medicine (Infectious Diseases) and, by courtesy, of Pathology
Current Research and Scholarly InterestsMy group’s research is on the mechanisms and consequences of virus evolution with a focus on HIV therapy and drug resistance. We maintain a public HIV drug resistance database (http://hivdb.stanford.edu) as a resource for HIV drug resistance surveillance, interpreting HIV drug resistance tests, and HIV drug development. Our paramount goal is to inform HIV treatment and prevention policies by identifying the main factors responsible for the emergence and spread of drug resistance.
-
Steven L. Shafer, MD
Professor of Anesthesiology, Perioperative and Pain Medicine (Adult MSD) at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsPharmacokinetics and pharmacodynamics of intravenous anesthetics, including drug interactions and continuous measures of drug effect; model-based drug development; target controlled drug delivery; advanced models of drug behavior.
-
Elaheh Shaghaghian, MD
Visiting Instructor, Neurosurgery
BioElaheh Shaghaghian, MD, is a Clinical Research Scholar at Stanford University's Neurosurgery Department, where she investigates the efficacy of CyberKnife Radiosurgery with an interdisciplinary team. Skilled in problem-solving, Elaheh has a fervent passion for learning and applying new medical technologies.
She earned her MD from Shiraz University of Medical Sciences, focusing on advancing medical treatments through research. With experience in clinical research, data analysis, and interdisciplinary collaboration, she is dedicated to leveraging technology to enhance healthcare outcomes. -
Ami J. Shah
Clinical Professor, Pediatrics - Stem Cell Transplantation
BioDr. Shah joined Stanford University in 2015 as a Clinical Professor of Pediatrics in the Division of Hematology/ Oncology, Stem Cell Transplantation and Regenerative Medicine. Dr. Shah completed medical school at the University of North Carolina- Chapel Hill. She completed her training in Pediatrics and Pediatric Hematology/ Oncology at Childrens Hospital Los Angeles. Her areas of clinical expertise have been in stem cell transplantation for malignant and non-malignant disorders. She has been actively involved with the care and treatment of children with primary immune deficiencies and is the site PI for the Primary Immune Deficiencies Consortium (PIDTC). She has experience in numerous gene therapy trials for primary immune deficiencies, hemoglobinopathies and other genetic diseases. She has a specific interest in the long term outcomes following HSCT, in specific the neurocognitive function post HSCT. She has been an active participant in American Society of Transplantation and Cellular Therapy (ASTCT), Children's Oncology Group (COG) and American Society of Hematology (ASH).
She has been actively involved with mentorship and graduate medical education, and currently serves as the Program Director for the Pediatric Hematology/ Oncology Fellowship and the Pediatric Stem Cell Fellowship. She also serves on the Pediatric Mentoring Group. -
Jay Shah
Associate Professor of Urology
BioDr. Jay Shah, MD currently serves as Immediate Past Chief of the Medical Staff for Stanford Health Care. He is a cancer surgeon and associate professor of Urology at the Stanford University School of Medicine. His clinical focus is on bladder cancer, and he is well known for his expertise in robotic surgery. Since his arrival to Stanford, he has started the Urology Department Quality Program, the Urologic Oncology Fellowship, the Urology Resident Coaching Program, and the Inpatient Urology Hospitalist Program. His academic interests center on optimizing outcomes after bladder cancer treatment. He is very active in leadership development, team building, and quality improvement work and he lectures nationally and internationally on these topics. He is certified by the International Coaching Federation as an executive coach. He also serves as a Training Group facilitator for the highly popular course, Interpersonal Dynamics, at the Stanford Graduate School of Business.
Dr. Shah graduated from Harvard College, and he completed medical school and urology residency training at Columbia University. During his time at Columbia, Dr. Shah was elected to the Alpha Omega Alpha Medical Honor Society; he was named Physician of the Year by the nursing staff; and he was recognized by the medical students with the Gold Foundation Excellence in Teaching Award. After residency, he completed a three-year fellowship in Urologic Oncology at MD Anderson Cancer Center and then joined the faculty there. During his time at MD Anderson, Dr. Shah launched the bladder cancer robotics program, developed an enhanced recovery program for patients undergoing bladder removal surgery, became double board-certified in Urology and Medical Quality, and was chosen to lead the MDACC Genitourinary Center as Center Medical Director.
In his free time, Dr. Shah enjoys reading, cooking, growing his own food, surfing, and exploring the beaches of Northern California with his three dogs. -
Mamta Madhav Shah, MD
Clinical Assistant Professor, Medicine - Nephrology
BioDr. Shah is a board-certified, fellowship-trained nephrologist and clinical assistant professor in the Department of Medicine, Division of Nephrology at Stanford University School of Medicine.
She completed her residency and fellowship training in Connecticut and was faculty at the University of Connecticut Health Center before moving to the Bay Area and Stanford. She provides care for patients with a variety of kidney-related conditions, with a special interest and clinical focus in metabolic evaluation and prevention of kidney stones. Her goal is to collaborate with each patient to develop a personalized and comprehensive care plan. She has given many talks on management of kidney stones to peers and trainees. She also has an interest in inpatient nephrology. Dr. Shah previously served as medical director of a University of Connecticut Health Center affiliated dialysis clinic during her time there, and helped run the plasmapheresis treatments. She continues to care for chronic hemodialysis patients since moving to Stanford.
Dr. Shah is a member and fellow of the American Society of Nephrology. She is closely involved in the education of trainees including medical students, residents and fellows. She served as core faculty of the Nephrology Fellowship at the University of Connecticut Health Center and continues to be involved in the fellowship training at Stanford as site director for the Nephrology Fellowship.
Dr. Shah’s work has been published in the Journal of Onco-Nephrology, Therapeutic Apheresis and Dialysis, and Connecticut Medicine. She has presented to her peers at national and regional meetings of the American Society of Nephrology, the National Kidney Foundation, and the American College of Physicians, Connecticut Chapter.
She is fluent in Hindi and Gujarati. Outside of work she enjoys traveling and spending time with her husband and children. -
Manish I. Shah, MD, MS
Professor of Emergency Medicine (Pediatrics) and, by courtesy, of Pediatrics (Hospital Medicine)
BioI have dedicated my career to improving pediatric prehospital care on local, statewide, national, and international levels through research, education, and advocacy. My primary research interest focuses on integration of pediatric evidence into emergency medical services (EMS) systems. I serve on the Executive Committee of the Pediatric Emergency Care Applied Research Network (PECARN) as the nodal Principal Investigator (PI) for the Charlotte, Houston, and Milwaukee Prehospital (CHaMP) research node. In addition, I am the PI for the Pediatric Dose Optimization for Seizures in EMS (PediDOSE) clinical trial and co-investigator for the Pediatric Prehospital Airway Resuscitation Trial (Pedi-PART). As an educational researcher, I have obtained several grants to produce an online EMS educational resource for physicians, create the Pediatric Simulation Training of Emergency Prehospital Providers (PediSTEPPs) program, and study the implementation of an EMS training curriculum for the Botswana Ministry of Health. As an EMS advocate, I led the Prehospital and State Partnership domains for the national EMS for Children (EMSC) Innovation and Improvement Center (EIIC), served as an appointed member of the National Emergency Medical Services Advisory Council (NEMSAC), chaired the EMS subcommittee for the American Academy of Pediatrics Section of Emergency Medicine, and directed the EMSC State Partnership in Texas. I have published policy on pediatric readiness in EMS systems and co-chaired the workgroup that created the first-ever national assessment of pediatric readiness of EMS systems for the National Prehospital Pediatric Readiness Project (PPRP).
-
Mona D. Shah, MD, MBA
Adjunct Clinical Associate Professor, Pediatrics - Hematology & Oncology
BioDr. Mona Shah is a pediatric hematologist-oncologist, who earned her MD degree at the University of Maryland in 2001. She completed both her categorical pediatrics and global health residencies in 2004, followed by a pediatric hematology-oncology fellowship in 2007. She earned her MS in Clinical Investigation as part of the Clinical Scientist Training Program (CSTP) at Baylor College of Medicine in 2011, and more recently, completed an Executive MBA at Rice University Jones School of Business in 2018.
Dr. Shah was an Associate Professor at Baylor College of Medicine (2007 - 2020) in both Pediatrics and Medicine, local site PI on a number of pediatric hemostasis/thrombosis clinical trials, and spent 10 years as an Associate Medical Director of Clinical Operations, Quality, and Safety at Texas Children’s Hospital, Houston, TX.
Dr. Shah joined Genentech (a Member of the Roche Group)’s Rare Blood Disorders Franchise (Product Development - Oncology-Hematology) in February 2020, quickly advancing to Lead Medical Director, where she served as Medical Monitor for 2 Phase III Clinical Trials (crovalimab in atypical hemolytic uremic syndrome, aHUS). She was also engaged with the Renal Franchise (I2O) in developing crovalimab in Lupus Nephritis (Phase I & II Clinical Trials in development), and with Human Factors/Pediatric Formulations Working Group on autoinjector devices and oral formulations.
After completing a rotation in Early Development Safety (EDS), she was promoted to Senior Medical Safety Director in Late Stage Product Development, and was appointed Safety Strategy Lead for giredestrant in early and metastatic breast, ovarian, and endometrial cancer global clinical trials. She has experience in innovative study designs (adaptive/multi-drug), with FDA/EMA pediatric investigational plans, and health authority interactions. In June 2023, she was appointed Pediatric Safety Lead, in collaboration with the iPODD Team, supporting safety for pediatric indications and devices, and serves as the Co-Chair of the Pediatric Safety Expert Group.
Dr. Shah has kept and completed a bucket list since she was 7 years old (keeps growing): Running wild bouldering/rock climbing as a child in the Shenandoah/Blue Ridge Mountains, swimming with dolphins/piranhas in the Amazon, climbing inside a volcano caldera in Iceland, snorkeling the Great Barrier Reef ... have passport/will travel!
Since July 2022, she has joined Stanford University School of Medicine, as an Adjunct Clinical Associate Professor in the Department of Pediatrics, Division of Hematology-Oncology, where she enjoys teaching MSII students, and at the bedside in the Lucille Packard Bass Center Hematology Clinic. Dr. Shah enjoys free time in her new home base near San Francisco, where she hosts her visiting parents, friends, and extended family. -
Neha Shah
Clinical Assistant Professor, Medicine - Immunology & Rheumatology
BioDr Shah's clinical and research interests lie in Integrative Rheumatology, healing-oriented medicine that takes account of the whole patient, including all aspects of lifestyle. It emphasizes the therapeutic relationship between practitioner and patient, is informed by evidence, and makes use of all appropriate therapies, including those outside the realm of allopathic medicine. Specifically, she is interested in exploring the impact of diet/nutrition/botanicals on inflammation as it pertains to rheumatic diseases such as gout, rheumatoid arthritis, lupus, psoriatic arthritis and other autoimmune conditions, as well as studying the impact of other lifestyle approaches such as mindful meditation, sleep, yoga, stress reduction, etc. on disease burden and quality of life of patients with rheumatic diseases. She boarded in Lifestyle Medicine and has advanced training in Functional Medicine. Dr Shah is currently pursuing additional training in Ayurvedic Medicine.
-
Nigam H. Shah, MBBS, PhD
Professor of Medicine (Computational Medicine), of Biomedical Data Science and, by courtesy, of Computer Science
Current Research and Scholarly InterestsWe answer clinical questions using aggregate patient data at the bedside. The Informatics Consult Service (https://greenbutton.stanford.edu/) put this idea in action and led to the creation of Atropos Health. We build predictive models that allow taking mitigating actions, keeping the human in the loop.
-
Nirao Shah
Professor of Psychiatry and Behavioral Sciences (Major Laboratories and Clinical Translational Neurosciences Incubator), of Neurobiology and, by courtesy, of Obstetrics and Gynecology
Current Research and Scholarly InterestsWe study how our brains generate social interactions that differ between the sexes. Such gender differences in behavior are regulated by sex hormones, experience, and social cues. Accordingly, we are characterizing how these internal and external factors control gene expression and neuronal physiology in the two sexes to generate behavior. We are also interested in understanding how such sex differences in the healthy brain translate to sex differences in many neuro-psychiatric illnesses.
-
Nirav R. Shah, MD, MPH
Adjunct Professor, Medicine - Primary Care and Population Health
BioNirav R. Shah, MD, MPH, is Senior Scholar at Stanford University’s School of Medicine. He is a distinguished healthcare leader with experience as an operator, scientist, innovator, and regulator. His expertise spans public health, digital health and generative AI, public and private health insurance, and clinical operations across the continuum of care. At Stanford, Dr. Shah conducts research on improving healthcare quality and safety while lowering cost, driving adoption of digital technologies, and quantitatively evaluating the resulting value for US and international health care systems. Dr. Shah is Board-certified in Internal Medicine and is a graduate of Harvard College and Yale School of Medicine. He is an Advisor to the CDC Director, Senior Fellow of the Institute for Healthcare Improvement (IHI), independent director of STERIS plc [NYSE:STE], and trustee of the John A. Hartford Foundation. Previously, he served as Chief Operating Officer of Kaiser Permanente in Southern California, and as Commissioner of the New York State Department of Health.
-
Reshma Shah
Adjunct Lecturer, Peds/Quality of Life and Pediatric Palliative Care
BioDr. Reshma Shah is an Adjunct Lecturer at Stanford University in the Department of Pediatrics / Quality of Life and Pediatric Palliative Care in the School of Medicine. She previously served as an Affiliate Clinical Instructor at Stanford University School of Medicine and has over 20 years of experience in academic and clinical pediatrics.
Dr. Shah’s work focuses on pediatric nutrition, plant-based dietary patterns, and family-centered approaches to health and well-being. She is the co-author of the award-winning book Nourish: The Definitive Plant-Based Nutrition Guide for Families and a contributing author to the American Academy of Pediatrics’ textbook on pediatric nutrition.
She holds a Master’s in Public Health and has additional training in plant-based nutrition. Dr. Shah is dedicated to integrating evidence-based nutrition guidance into pediatric care to support the health of children and families.
Most Sundays, you can find her at her local farmers market, where she finds inspiration for nourishing meals and meaningful family connections. -
Ripal Shah
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioRipal Shah, M.D., M.P.H. is a Clinical Associate Professor at the Stanford University School of Medicine. Before her time at Stanford, she completed an M.P.H. at Harvard University in Health Care Management and Policy, an M.D. from the Mount Sinai School of Medicine in New York with tuition merit scholarship, and a B.S. from Duke University in Economics and Biochemistry. Dr. Shah is board certified in Adult Psychiatry, Addiction Medicine, Obesity Medicine, and Integrative Medicine, and is board-eligible in Longevity Medicine. She specializes clinically in the care of women, high performers, and those seeking non-pharmaceutical approaches to health.
Dr. Shah's clinical expertise are in reproductive psychiatry (pre-conception, pregnancy, postpartum, breastfeeding, fertility, pre-menstrual dysphoric disorder (PMDD), sexual health disorders, menopause), lifestyle and integrative approaches to health (vitamins, supplements, exercise, behavioral change, hypnosis, longevity), and in high performers such as physicians and CEOs. She leads the Longevity Medicine, Weight Management, and Integrative Mental Health programs in the Stanford Center for Integrative Medicine. Dr. Shah is regarded as one of the world's experts in PMDD, and one of very few specifically studying PMDD in women of color.
Her research areas of focus are on women's reproductive psychiatry, evidence-based longevity medicine, ethnicity-dependent variability in mental health access and treatment response, psychedelics, the role of Eastern religions on mental health in the U.S., and how psychological science can help us overcome the loneliness epidemic. Outside of consultations, she specializes in psychotherapy for those struggling with relationships or loss of a partnership; grief or loss of a parent, sibling, child, or spouse; issues related to identity (religious identification, racial/ethnic minority stress, racial trauma, professional transitions, changes in family structure or relational status, sexual orientation); as well as cognitive-behavioral therapy for ADHD and anxiety disorders. She has received specialized training in working with Black and South Asian populations.
While in training at Stanford, Dr. Shah served as Chief Resident and led community partnerships. She consistently ranked #1 in the Stanford residency (and top 1% in the nation) on the annual knowledge-based examination (PRITE). She is a Disaster Mental Health Responder both domestically and internationally, volunteering after wildfires, hurricanes, and earthquakes in over 20 countries. She founded the Diversity & Inclusion Advisory Council (DIAC), now implemented at psychiatry programs across the country, and created the first known Diversity & Health Equity Grand Rounds series. She served as Chair of the Chief Residents’ Council, representing over a thousand physicians to the Stanford Health Care leadership.
Dr. Shah pursued additional training in the fields of Emergency Medicine and Internal Medicine. She has been credentialed in TMS, ECT, hypnosis, and ketamine infusions. She completed a Certificate in Psychedelic-Assisted Therapies and Research, with training from the Multidisciplinary Association for Psychedelic Studies (MAPS), and also completed MAPS' program MDMA Assisted Therapy Researcher Training. She is on the MDMA Clinical/Monitoring Team for Stanford's Pilot Study of 3,4-Methylenedioxymethamphetamine (MDMA)-Assisted Cognitive Behavior Therapy for Obsessive Compulsive Disorder: (MDMA+CBT-4-OCD).
Dr. Shah serves as a clinical advisor for several start-ups and large companies, advises research teams on the clinical use of psychedelics in psychiatry, and often consults with media and tech companies as an industry expert. She has given talks all over the world, from physician-scientist audiences, to C-suite retreats. She has been seen in TIME, Forbes, and the Washington Post, and in 2020 was awarded one of the top 25 rising stars in medicine by Medscape. -
Sajan Shah, MD, MBA
Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine
BioDr. Sajan Shah is a board-certified, fellowship-trained pain management specialist with the Stanford Health Care Pain Management Center. He is also a clinical assistant professor in the Department of Anesthesiology, Perioperative and Pain Medicine, Division of Pain Medicine at Stanford University School of Medicine.
Dr. Shah specializes in managing acute and chronic pain. He commonly cares for people living with complex spinal conditions that have not responded to conventional treatment. He offers a range of injections to manage pain, including joint corticosteroid injections, peripheral nerve blocks, trigger point injections, and Botox injections for migraines and dystonia. He has experience with neuromodulation techniques, including spinal cord stimulation and peripheral nerve stimulation, and minimally invasive spinal procedures. He strives to provide effective pain therapies that improve the everyday function and quality of life of his patients.
Dr. Shah’s research has explored topics in anesthesiology and pain medicine. He has studied chronic pain syndromes, including how to diagnose and manage rare pain conditions. Dr. Shah has published his findings in several peer-reviewed journals and co-authored a book chapter on complex regional pain syndrome. He has presented his research at national and international meetings, including those held by the American Academy of Pain Medicine, American Society of Regional Anesthesia and Pain Medicine, and North American Neuromodulation Society. -
Sejal Shah
Clinical Associate Professor, Pediatrics - Endocrinology
Current Research and Scholarly InterestsMy primary research interest is evaluating whether vitamin D supplementation can positively affect consequences of the metabolic syndrome in overweight and obese adolescents. Other research interests include evaluating the efficacy and biochemical profiles of various types of estrogen replacement in adolescent females.
-
Sumit Shah
Clinical Associate Professor, Medicine - Oncology
Clinical Associate Professor (By courtesy), UrologyBioDr. Sumit Shah is a medical oncologist specializing in the management of advanced urologic malignancies, including prostate, bladder, kidney, and testicular cancers. He is actively involved in clinical trials, with a particular focus on novel immunotherapy agents and biomarkers to select patients most likely to benefit from therapy. His academic interests also encompass digital health technologies and innovative healthcare delivery models. He has lectured internationally on the management of urologic cancers and currently serves on the National Cancer Center Network (NCCN) Panel for testicular cancer.
Dr. Shah graduated with distinction in biomedical engineering from Duke University, earned his MD from Stanford University, and completed a Master of Public Health at Harvard University. He trained in internal medicine at the University of California, San Francisco (UCSF), where he remained on faculty for one year before returning to Stanford for his fellowship in medical oncology. He now holds a faculty position in the Department of Medicine (Oncology) at Stanford.
In addition to his clinical and research roles, Dr. Shah serves as Medical Director of Digital Healthcare Integration and Director of Infusion Services at Stanford Hospital. He is also Assistant Dean of Academic Advising in the Stanford School of Medicine. -
Shagufta Shaheen
Clinical Assistant Professor, Medicine - Oncology
BioDr. Shaheen specializes in the gastrointestinal malignancies and she has expertise in treating neuroendocrine tumors (NETs). Following her fellowship in Hematology and Oncology, Dr Shaheen completed an advanced fellowship in Neuroendocrine tumors from Stanford University. The NET advanced fellowship is first of its kind in United State started under the leadership of Dr Pamela Kunz who is the founding Director of the Stanford Neuroendocrine Tumor Program established in 2015. After completing her advanced fellowship, Dr Shaheen joined Stanford Oncology division as Clinical Assistant Professor. Dr Shaheen is involved in further developing the neuroendocrine oncology program at Stanford which serves as a centre of excellence in the treatment of neuroendocrine tumors. Dr Shaheen is actively involved in clinical research and clinical trials. Dr Shaheen is also involved in taking care of patients admitted to the oncology service as well as resident and fellow teaching.
-
Mohammad Shahrokh Esfahani
Assistant Professor of Radiation Oncology (Radiation and Cancer Biology)
BioI lead a computational oncology laboratory that develops machine learning and statistical methods for high-dimensional genomics, with particular expertise in Bayesian and uncertainty-aware modeling to integrate prior biological knowledge with large-scale datasets.
Our research centers on liquid biopsy analytics—especially cell-free DNA (cfDNA)—to noninvasively quantify genetic and epigenetic states relevant to cancer detection, monitoring, and tumor evolution. We developed EPIC-seq, a fragmentomics-based method that uses cfDNA fragmentation patterns to infer regulatory activity and gene expression programs, providing a scalable framework for epigenetic profiling from blood.
A core methodological focus of the lab is enabling reliable inference in extremely low signal-to-noise settings that are typical of cfDNA and early-stage disease. We build robust, interpretable models and benchmarking frameworks that support clinical translation, with the long-term aim of democratizing access to sensitive, minimally invasive cancer diagnostics.
